Clinical Trial Detail

NCT ID NCT03666988
Title First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

urethra transitional cell carcinoma

pancreatic adenocarcinoma

Advanced Solid Tumor

relapsed/refractory diffuse large B-cell lymphoma

lung non-small cell carcinoma

Therapies

GSK3368715

Age Groups: senior adult

Additional content available in CKB BOOST